Copyright
©The Author(s) 2017.
World J Gastroenterol. Jan 14, 2017; 23(2): 265-274
Published online Jan 14, 2017. doi: 10.3748/wjg.v23.i2.265
Published online Jan 14, 2017. doi: 10.3748/wjg.v23.i2.265
Variable | No. of patients |
Mean age ± SD (yr) | 60.3 ± 9.0 |
Sex (male) | 32 |
Pathology | |
Adenocarcinoma | 43 |
Cystadenocarcinoma | 2 |
Invasive IPMN | 4 |
Acinar adenocarcinoma | 1 |
Adenosquamous carcinoma | 1 |
Renal cell carcinoma metastasis | 1 |
Tumor location | |
Head | 28 |
Corpus | 15 |
Tail | 3 |
> 1 location | 6 |
Median primary tumor size (IQR) (cm) | 4.7 (3.0-6.0) |
Venous invasion | 26 |
Lymph node invasion | 18 |
Splenectomy | 11 |
Operative time (IQR) (min) | 472.5 (421.3-548.8) |
Operative arrangement | |
Planned | 20 |
Unplanned | 32 |
Postoperative complication1 | |
Gastroplegia | 4 |
Gastrointestinal or abdominal hemorrhage bleeding | 1 |
Pneumonia | 14 |
Abdominal infection | 9 |
Hepatic failure | 1 |
Respiratory failure | 1 |
Length of postoperative hospital stay (IQR) (d) | 12.0 (10.0-17.8) |
Neoadjuvant treatment | 14 |
Adjuvant treatment | 52 |
Median recurrence-free time (IQR) (mo) | 4.7 (2.7-13.6) |
Median survival time (IQR) (mo) | 20.9 (10.2-51.0) |
1-year survival (%) | 63.4 |
3-year survival (%) | 24.2 |
5-year survival (%) | 12.5 |
Preop | Postop1 | Postop 1 mo | Postop 3 mo | Postop 6 mo | Postop 12 mo | P value2 | |
FBG (mg/dL) | 130 ± 60 | 154 ± 39 | 153 ± 84 | 167 ± 94 | 149 ± 68 | 142 ± 79 | 0.078 |
HbA1c (%) | 6.7 ± 1.5 | / | 6.7 ± 0.8 | 7.2 ± 1.0 | 6.8 ± 0.8 | 6.5 ± 0.8 | 0.330 |
BMI (kg/m2) | 22.3 ± 3.2 | / | 21.2 ± 3.0 | 20.6 ± 2.8 | 20.3 ± 3.0 | 19.6 ± 2.5 | 0.001 |
Total protein (g/L) | 65.7 ± 9.2 | 60.4 ± 6.6 | 68.4 ± 5.8 | 66.4 ± 4.9 | 67.2 ± 8.5 | 67.8 ± 6.3 | 0.369 |
Albumin (g/L) | 39.3 ± 4.0 | 38.0 ± 4.2 | 38.2 ± 4.0 | 36.2 ± 4.4 | 38.0 ± 7.7 | 38.8 ± 4.6 | 0.933 |
Prealbumin (mg/L) | 203.9 ± 54.3 | 171.6 ± 40.8 | 135.3 ± 34.6 | 147.9 ± 42.0 | 145.9 ± 48.8 | 148.2 ± 54.6 | 0.001 |
PNI | 46.0 ± 3.4 | 47.8 ± 6.3 | 44.6 ± 4.0 | 43.8 ± 5.9 | 42.7 ± 5.9 | 47.3 ± 4.8 | 0.244 |
Variable | Multivariate analysis | ||
Odds ratio/hazard ratio | 95%CI | P value | |
Complications | |||
Postop FBG1 | |||
< 155 mg/dL | |||
≥ 155 mg/dL | 4.074 | 1.188-13.965 | 0.025 |
Postop prealbumin1 | |||
> 185 mg/L | |||
≤ 185 mg/L | 3.816 | 1.110-13.122 | 0.034 |
Recurrence-free survival | |||
Preop FBG | |||
≤ 110 mg/dL | |||
> 110 mg/dL | 2.330 | 1.204-4.510 | 0.012 |
Venous invasion | |||
No | |||
Yes | 2.975 | 1.502-5.892 | 0.002 |
Postop HbA1c1 | |||
< 7% | |||
≥ 7% | 2.655 | 1.299-5.425 | 0.007 |
Postop PNI1 | |||
> 45 | |||
≤ 45 | 1.760 | 0.897-3.455 | 0.100 |
Overall survival | |||
Diabetes mellitus | |||
No | |||
Short-term | 0.943 | 0.300-2.965 | 0.920 |
Long-term | 2.305 | 0.560-9.483 | 0.247 |
Preop FBG | |||
≤ 110 mg/dL | |||
> 110 mg/dL | 1.112 | 0.357-3.462 | 0.854 |
Postop HbA1c2 | |||
< 7% | |||
≥ 7% | 3.212 | 1.147-8.999 | 0.026 |
Postop total protein2 | |||
> 55 g/L | |||
≤ 55 g/L | 1.152 | 0.304-4.364 | 0.835 |
Postop albumin2 | |||
> 35 g/L | |||
≤ 35 g/L | 2.894 | 0.551-15.195 | 0.209 |
Postop prealbumin2 | |||
> 185 mg/L | |||
≤ 185 mg/L | 3.961 | 0.976-16.068 | 0.054 |
Postop PNI2 | |||
> 45 | |||
≤ 45 | 1.143 | 0.242-5.408 | 0.866 |
- Citation: Shi HJ, Jin C, Fu DL. Impact of postoperative glycemic control and nutritional status on clinical outcomes after total pancreatectomy. World J Gastroenterol 2017; 23(2): 265-274
- URL: https://www.wjgnet.com/1007-9327/full/v23/i2/265.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i2.265